Vanguard Group Inc. Trims Holdings in National Health Investors, Inc. (NYSE:NHI)

Vanguard Group Inc. cut its position in shares of National Health Investors, Inc. (NYSE:NHI) by 0.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,146,344 shares of the real estate investment trust’s stock after selling 27,008 shares during the quarter. Vanguard Group Inc. owned approximately 14.16% of National Health Investors worth $343,273,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of NHI. Rhumbline Advisers boosted its stake in National Health Investors by 1.4% in the 3rd quarter. Rhumbline Advisers now owns 79,499 shares of the real estate investment trust’s stock worth $4,083,000 after buying an additional 1,085 shares during the last quarter. Invesco Ltd. grew its holdings in National Health Investors by 12.0% in the third quarter. Invesco Ltd. now owns 286,887 shares of the real estate investment trust’s stock valued at $14,735,000 after purchasing an additional 30,834 shares during the period. Connor Clark & Lunn Investment Management Ltd. increased its position in National Health Investors by 36.2% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 14,743 shares of the real estate investment trust’s stock worth $757,000 after purchasing an additional 3,916 shares during the last quarter. Employees Retirement System of Texas raised its stake in National Health Investors by 75.0% during the third quarter. Employees Retirement System of Texas now owns 35,000 shares of the real estate investment trust’s stock worth $1,798,000 after purchasing an additional 15,000 shares during the period. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of National Health Investors by 8.0% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 62,812 shares of the real estate investment trust’s stock valued at $3,226,000 after purchasing an additional 4,676 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

Insider Transactions at National Health Investors

In related news, Director Robert A. Mccabe, Jr. purchased 437 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The shares were purchased at an average cost of $65.83 per share, with a total value of $28,767.71. Following the completion of the acquisition, the director now directly owns 21,585 shares of the company’s stock, valued at approximately $1,420,940.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 7.26% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on NHI shares. Wells Fargo & Company increased their target price on National Health Investors from $63.00 to $69.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Truist Financial increased their target price on shares of National Health Investors from $58.00 to $65.00 and gave the stock a “hold” rating in a research report on Wednesday. BMO Capital Markets raised shares of National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price target on the stock in a research report on Tuesday, March 12th. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Finally, Wedbush lifted their target price on shares of National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a report on Monday, March 18th. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $62.13.

National Health Investors Stock Up 0.2 %

Shares of NYSE NHI opened at $67.72 on Friday. The firm has a market cap of $2.94 billion, a price-to-earnings ratio of 22.20 and a beta of 1.00. National Health Investors, Inc. has a 1 year low of $48.51 and a 1 year high of $68.14. The company has a debt-to-equity ratio of 0.91, a quick ratio of 13.24 and a current ratio of 13.24. The stock’s 50-day simple moving average is $65.49 and its 200-day simple moving average is $59.97.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 2nd. Shareholders of record on Friday, June 28th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.32%. The ex-dividend date is Friday, June 28th. National Health Investors’s payout ratio is 118.03%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.